Ticker Details
Crinetics Pharmaceuticals, Inc.
IPO Date:	July 16, 2018
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$8.84B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.76 | 2.84%
Avg Daily Range (30 D):	$2.19 | 5.52%
Avg Daily Range (90 D):	$1.36 | 3.49%

Institutional Daily Volume
Avg Daily Volume:	.46M
Avg Daily Volume (30 D):	4.34M
Avg Daily Volume (90 D):	2.15M

Trade Size
Avg Trade Size (Sh.):	68
Avg Trade Size (Sh.) (30 D):	180
Avg Trade Size (Sh.) (90 D):	106

Institutional Trades
Total Institutional Trades:	3,692
Avg Institutional Trade:	$3.64M
Avg Institutional Trade (30 D):	$6.93M
Avg Institutional Trade (90 D):	$6.06M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.87M
Avg Closing Trade (30 D):	$15.89M
Avg Closing Trade (90 D):	$9.44M
Avg Closing Volume:	131.64K

News

Jul 8, 2026 @ 6:35 PM Halper Sadeh LLC is Investigating Whether CRNX, ES... Source: Halper Sadeh Llc

Jul 8, 2026 @ 2:22 PM Vertex’s Crinetics Deal Balances Growth wit... Source: Chris Markoch

Jul 8, 2026 @ 7:28 AM Vertex Is Paying a 102% Premium to Acquire Crineti... Source: Eric Volkman

Jun 14, 2026 @ 8:30 PM Crinetics Presents Full Results From Phase 2 Trial... Source: Crinetics Pharmaceuticals, Inc.

Jun 14, 2026 @ 6:45 PM Crinetics Presents Long Term Data at ENDO 2026 Con... Source: Na

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-5.13	$-1.23	$-1.29
Diluted EPS	$-5.13	$-1.23	$-1.29
Revenue	$18.07M	$10.73M	$6.16M
Gross Profit		$10.53M
Net Income / Loss	$-496.39M	$-127.85M	$-122.82M
Operating Income / Loss	$-545.74M	$-140.38M	$-133.67M
Cost of Revenue	$1.28M	$.2M
Net Cash Flow	$19.39M	$12.81M	$-9.76M
PE Ratio